Associated Papers
Alpha-methyl-para-tyrosine and amphetamine ameliorate hyperactivity in a novel mouse model of dopamine transporter deficiency syndrome.
Russo EE et al.
Embo Molecular Medicine, 2026
Leaky lessons learned: Efflux prone dopamine transporter variant reveals sex and circuit specific contributions of D2 receptor signalling to neuropsychiatric disease.
Mayer FP et al.
Basic & Clinical Pharmacology & Toxicology, 2024
The dopamine transporter gene SLC6A3: multidisease risks.
Reith MEA et al.
Molecular Psychiatry, 2022
Functional and Biochemical Consequences of Disease Variants in Neurotransmitter Transporters: A Special Emphasis on Folding and Trafficking Deficits.
Bhat S et al.
Pharmacology & Therapeutics, 2021
Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes.
Herborg F et al.
The Journal of Biological Chemistry, 2018
Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.
Mergy MA et al.
Neurochemistry International, 2014
Human genetics and pharmacology of neurotransmitter transporters.
Lin Z et al.
Handbook of Experimental Pharmacology, 2006
ADHD and the dopamine transporter: are there reasons to pay attention?
Mazei-Robinson MS et al.
Handbook of Experimental Pharmacology, 2006
A dopamine transporter mutation associated with bipolar affective disorder causes inhibition of transporter cell surface expression.
Horschitz S et al.
Molecular Psychiatry, 2005
Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382Ala.
Mazei-Robison MS et al.
Neuropharmacology, 2005
Human dopamine transporter gene variation: effects of protein coding variants V55A and V382A on expression and uptake activities.
Lin Z et al.
The Pharmacogenomics Journal, 2003
The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders.
Bannon MJ et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology, 2001
Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder.
Barr CL et al.
Biological Psychiatry, 2001
Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1).
Grünhage F et al.
Molecular Psychiatry, 2000